Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

Earnings Preview: What To Expect From DexCom's Report

Valued at a market cap of $27.5 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.

DXCM is expected to release its Q2 2026 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $0.61 on a diluted basis, up 27.1% from $0.48 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.